Trial Profile
Prospective study investigating improvement in glycemic control after meal tolerance test in type 2 diabetes mellitus patients receiving vildagliptin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Dec 2015 New trial record